AlzChem Group AG Stock
€139.80
Your prediction
AlzChem Group AG Stock
Pros and Cons of AlzChem Group AG in the next few years
Pros
Cons
Performance of AlzChem Group AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AlzChem Group AG | -1.270% | -11.940% | -3.935% | 156.522% | 150.177% | 766.055% | 673.770% |
| adesso SE | 0.440% | -2.473% | -6.974% | 44.888% | 3.185% | -10.904% | 17.183% |
| CENIT AG | 0.280% | 0.845% | -0.279% | -20.444% | -1.241% | -47.737% | -42.720% |
| Allgeier SE | -0.290% | -7.609% | -5.028% | 21.429% | 14.094% | -41.681% | -71.667% |

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Looking at the financials of AlzChem, a company in the Software & IT Services industry, one can observe a positive trend in the company's growth. Net income and total assets have gradually increased over the past three years, which is generally a positive sign. However, a closer examination of various financial aspects is necessary for a comprehensive analysis.
*Pros: *
Growth in total assets: The total assets for AlzChem have experienced consistent growth over the last three years, from €354.3 million in 2020 to €422.8 million in 2022. This growth reflects an improvement in the company's overall financial health.
Comments
News
EQS-News: Successful nine-month results for 2025: Alzchem Group AG increases EBITDA by 12% and confirms forecast for record year in 2025
Alzchem Group AG and Ehrmann launch cooperation: New high-protein creatine products with Creavitalis® available in stores from October


